Annual revenue:
$182.95M+$165.51M(+948.62%)Summary
- As of today (September 15, 2025), TARS annual revenue is $182.95 million, with the most recent change of +$165.51 million (+948.62%) on December 31, 2024.
- During the last 3 years, TARS annual revenue has risen by +$125.93 million (+220.82%).
- TARS annual revenue is now at all-time high.
Performance
TARS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$102.66M+$24.32M(+31.05%)Summary
- As of today (September 15, 2025), TARS quarterly revenue is $102.66 million, with the most recent change of +$24.32 million (+31.05%) on June 30, 2025.
- Over the past year, TARS quarterly revenue has increased by +$61.85 million (+151.54%).
- TARS quarterly revenue is now at all-time high.
Performance
TARS Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$295.52M+$61.85M(+26.47%)Summary
- As of today (September 15, 2025), TARS TTM revenue is $295.52 million, with the most recent change of +$61.85 million (+26.47%) on June 30, 2025.
- Over the past year, TARS TTM revenue has increased by +$212.15 million (+254.45%).
- TARS TTM revenue is now at all-time high.
Performance
TARS TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TARS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +948.6% | +151.5% | +254.4% |
| 3 y3 years | +220.8% | +572.0% | +1599.0% |
| 5 y5 years | +100.0% | - | - |
TARS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +948.6% | at high | >+9999.0% | at high | +2264.2% |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
TARS Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $102.66M(+31.1%) | $295.52M(+26.5%) |
| Mar 2025 | - | $78.33M(+18.0%) | $233.67M(+27.7%) |
| Dec 2024 | $182.95M(+948.6%) | $66.41M(+38.0%) | $182.95M(+41.1%) |
| Sep 2024 | - | $48.12M(+17.9%) | $129.62M(+55.5%) |
| Jun 2024 | - | $40.81M(+47.8%) | $83.37M(+95.9%) |
| Mar 2024 | - | $27.61M(+111.2%) | $42.56M(+143.9%) |
| Dec 2023 | $17.45M(-32.4%) | $13.08M(+598.9%) | $17.45M(+21.4%) |
| Sep 2023 | - | $1.87M(>+9900.0%) | $14.37M(+15.0%) |
| Jun 2023 | - | $0.00(-100.0%) | $12.50M(-55.0%) |
| Mar 2023 | - | $2.50M(-75.0%) | $27.78M(+7.6%) |
| Dec 2022 | $25.82M | $10.00M(>+9900.0%) | $25.82M(+59.8%) |
| Sep 2022 | - | $0.00(-100.0%) | $16.15M(-7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $15.28M(+2734.3%) | $17.39M(-27.9%) |
| Mar 2022 | - | $539.00K(+59.5%) | $24.13M(-57.7%) |
| Dec 2021 | $57.03M(>+9900.0%) | $338.00K(-72.7%) | $57.03M(+0.6%) |
| Sep 2021 | - | $1.24M(-94.4%) | $56.69M(+2.2%) |
| Jun 2021 | - | $22.02M(-34.1%) | $55.45M(+65.9%) |
| Mar 2021 | - | $33.43M(>+9900.0%) | $33.43M(>+9900.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | - | - |
| Sep 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $0.00 | - | - |
FAQ
- What is Tarsus Pharmaceuticals, Inc. annual revenue?
- What is the all time high annual revenue for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. annual revenue year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. quarterly revenue?
- What is the all time high quarterly revenue for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. quarterly revenue year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. TTM revenue?
- What is the all time high TTM revenue for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. TTM revenue year-on-year change?
What is Tarsus Pharmaceuticals, Inc. annual revenue?
The current annual revenue of TARS is $182.95M
What is the all time high annual revenue for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high annual revenue is $182.95M
What is Tarsus Pharmaceuticals, Inc. annual revenue year-on-year change?
Over the past year, TARS annual revenue has changed by +$165.51M (+948.62%)
What is Tarsus Pharmaceuticals, Inc. quarterly revenue?
The current quarterly revenue of TARS is $102.66M
What is the all time high quarterly revenue for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high quarterly revenue is $102.66M
What is Tarsus Pharmaceuticals, Inc. quarterly revenue year-on-year change?
Over the past year, TARS quarterly revenue has changed by +$61.85M (+151.54%)
What is Tarsus Pharmaceuticals, Inc. TTM revenue?
The current TTM revenue of TARS is $295.52M
What is the all time high TTM revenue for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high TTM revenue is $295.52M
What is Tarsus Pharmaceuticals, Inc. TTM revenue year-on-year change?
Over the past year, TARS TTM revenue has changed by +$212.15M (+254.45%)